COVID-19 Vaccines
Infectious Disease·MeSH: COVID-19
Prevalence
10000.0 / 100K
Incidence
5000.0 / 100K/yr
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for COVID-19 Vaccines?
BioSniper tracks 2 drugs in development for COVID-19 Vaccines across 1 company.
How many clinical trials target COVID-19 Vaccines?
There are 1 clinical trial targeting COVID-19 Vaccines tracked by BioSniper.
What is the prevalence of COVID-19 Vaccines?
The estimated prevalence of COVID-19 Vaccines is approximately 10000.0 per 100,000 population.
Deep-dive into COVID-19 Vaccines
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis